Stable isotope synthesis of glycine transporter 1 inhibitor Iclepertin (BI 425809) and its major metabolites.

J Labelled Comp Radiopharm

The Radiosynthesis Laboratory, Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.

Published: November 2023

Stable isotope labeled Iclepertin (BI 425809, 1) and its major metabolites are needed as internal standards in bioanalytical studies. BI 425809 consists of two main building blocks, 5-methylsulfonyl-2-[(1R)-2,2,2-trifluoro-1-methyl-ethoxy]benzoic acid (2) and 3-[(1R,5R)-3-azabicyclo[3.1.0]hexan-5-yl]-5-(trifluoromethyl)isoxazole (3) linked to each other via an amide bond. We used fluoro[ C ]benzene as the starting material in the preparation of [ C ]-2. This intermediate was then employed to access carbon 13 labeled Iclepertin ([ C ]-1) and other metabolites. The major metabolite BI 761036 (6), which resulted from cytochrome P450 oxidation and amide hydrolysis of BI 425809, was prepared labeled with carbon 13 and nitrogen 15 via two synthetic routes. In the first route, diethyl [ C ]malonate, [ C]methyl iodide, and hydroxyl[ N]amine were used to provide [ C , N]-BI 761036 ([ C , N]-6a) in 13 steps in 6% overall yield, whereas in the second route, [ C ]propargyl alcohol, potassium [ C]cyanide, and [ N]ammonia were used to furnish [ C , N]-BI 761036 ([ C , N]-6b) in 11 steps in 1% overall yield. The detailed stable isotope synthesis of 1 and its major metabolites is described.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jlcr.4063DOI Listing

Publication Analysis

Top Keywords

stable isotope
12
major metabolites
12
isotope synthesis
8
iclepertin 425809
8
425809 major
8
labeled iclepertin
8
n]-bi 761036
8
steps yield
8
synthesis glycine
4
glycine transporter
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!